Toggle navigation
Publications Repository
Publications Repository
Toggle navigation
View item
Home
ICR Divisions
Clinical Studies
View item
Home
ICR Divisions
Clinical Studies
View item
JavaScript is disabled for your browser. Some features of this site may not work without it.
A Phase 1, Dose Escalation Study of Guadecitabine (SGI-110) in Combination with Pembrolizumab in Patients with Solid Tumours
View/
Open
Accepted version (9.375Mb)
ICR Author
Yap, Christina
Author
Yap, C
Type
Journal Article
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/5047
Collections
Clinical Studies
Research team
Clinical Trials & Statistics Unit
Language
eng
Date accepted
2022-03-15
License start date
2022-03-15
Citation
Journal for ImmunoTherapy of Cancer
Publisher
BioMed Central
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Browse
All of ICR repository
ICR Divisions
By issue date
Authors
Titles
Publication Types
This collection
By issue date
Authors
Titles
Publication Types